FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016356630> ?p ?o ?g. }

• W2016356630 endingPage "e27919" @default.
• W2016356630 startingPage "e27919" @default.
• W2016356630 abstract "Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality is a competing risk (CR) for LTFU; however, it is often overlooked in cohort analyses. We examined how the CR of death affected LTFU estimates in Zambia and Switzerland.HIV-infected patients aged ≥18 years who started ART 2004-2008 in observational cohorts in Zambia and Switzerland were included. We compared standard Kaplan-Meier curves with CR cumulative incidence. We calculated hazard ratios for LTFU across CD4 cell count strata using cause-specific Cox models, or Fine and Gray subdistribution models, adjusting for age, gender, body mass index and clinical stage. 89,339 patients from Zambia and 1,860 patients from Switzerland were included. 12,237 patients (13.7%) in Zambia and 129 patients (6.9%) in Switzerland were LTFU and 8,498 (9.5%) and 29 patients (1.6%), respectively, died. In Zambia, the probability of LTFU was overestimated in Kaplan-Meier curves: estimates at 3.5 years were 29.3% for patients starting ART with CD4 cells <100 cells/µl and 15.4% among patients starting with ≥ 350 cells/µL. The estimates from CR cumulative incidence were 22.9% and 13.6%, respectively. Little difference was found between naïve and CR analyses in Switzerland since only few patients died. The results from Cox and Fine and Gray models were similar: in Zambia the risk of loss to follow-up and death increased with decreasing CD4 counts at the start of ART, whereas in Switzerland there was a trend in the opposite direction, with patients with higher CD4 cell counts more likely to be lost to follow-up.In ART programmes in low-income settings the competing risk of death can substantially bias standard analyses of LTFU. The CD4 cell count and other prognostic factors may be differentially associated with LTFU in low-income and high-income settings." @default.
• W2016356630 created "2016-06-24" @default.
• W2016356630 creator A5011657274 @default.
• W2016356630 creator A5015277723 @default.
• W2016356630 creator A5018546528 @default.
• W2016356630 creator A5019896304 @default.
• W2016356630 creator A5020383961 @default.
• W2016356630 creator A5039985712 @default.
• W2016356630 creator A5051000428 @default.
• W2016356630 creator A5051693361 @default.
• W2016356630 creator A5052633473 @default.
• W2016356630 creator A5059371192 @default.
• W2016356630 creator A5065174129 @default.
• W2016356630 creator A5077161809 @default.
• W2016356630 creator A5084303270 @default.
• W2016356630 date "2011-12-19" @default.
• W2016356630 modified "2023-09-26" @default.
• W2016356630 title "Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland" @default.
• W2016356630 cites W1567051068 @default.
• W2016356630 cites W1966805252 @default.
• W2016356630 cites W1973489201 @default.
• W2016356630 cites W1973617793 @default.
• W2016356630 cites W1979214055 @default.
• W2016356630 cites W1986123457 @default.
• W2016356630 cites W1988105793 @default.
• W2016356630 cites W1991622062 @default.
• W2016356630 cites W1992237955 @default.
• W2016356630 cites W2001368382 @default.
• W2016356630 cites W2004009085 @default.
• W2016356630 cites W2004993190 @default.
• W2016356630 cites W2019954567 @default.
• W2016356630 cites W2022542927 @default.
• W2016356630 cites W2031368727 @default.
• W2016356630 cites W2038981426 @default.
• W2016356630 cites W2057847137 @default.
• W2016356630 cites W2071109714 @default.
• W2016356630 cites W2089103944 @default.
• W2016356630 cites W2093749928 @default.
• W2016356630 cites W2098949002 @default.
• W2016356630 cites W2103350910 @default.
• W2016356630 cites W2107627025 @default.
• W2016356630 cites W2112890913 @default.
• W2016356630 cites W2131080047 @default.
• W2016356630 cites W2133166320 @default.
• W2016356630 cites W2133652309 @default.
• W2016356630 cites W2139265966 @default.
• W2016356630 cites W2139894829 @default.
• W2016356630 cites W2154746519 @default.
• W2016356630 cites W2155999101 @default.
• W2016356630 cites W2157981460 @default.
• W2016356630 cites W2160888326 @default.
• W2016356630 cites W2163477848 @default.
• W2016356630 cites W2207308994 @default.
• W2016356630 doi "https://doi.org/10.1371/journal.pone.0027919" @default.
• W2016356630 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3242760" @default.
• W2016356630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22205933" @default.
• W2016356630 hasPublicationYear "2011" @default.
• W2016356630 type Work @default.
• W2016356630 sameAs 2016356630 @default.
• W2016356630 citedByCount "54" @default.
• W2016356630 countsByYear W20163566302012 @default.
• W2016356630 countsByYear W20163566302013 @default.
• W2016356630 countsByYear W20163566302014 @default.
• W2016356630 countsByYear W20163566302015 @default.
• W2016356630 countsByYear W20163566302016 @default.
• W2016356630 countsByYear W20163566302017 @default.
• W2016356630 countsByYear W20163566302018 @default.
• W2016356630 countsByYear W20163566302019 @default.
• W2016356630 countsByYear W20163566302020 @default.
• W2016356630 countsByYear W20163566302021 @default.
• W2016356630 countsByYear W20163566302022 @default.
• W2016356630 crossrefType "journal-article" @default.
• W2016356630 hasAuthorship W2016356630A5011657274 @default.
• W2016356630 hasAuthorship W2016356630A5015277723 @default.
• W2016356630 hasAuthorship W2016356630A5018546528 @default.
• W2016356630 hasAuthorship W2016356630A5019896304 @default.
• W2016356630 hasAuthorship W2016356630A5020383961 @default.
• W2016356630 hasAuthorship W2016356630A5039985712 @default.
• W2016356630 hasAuthorship W2016356630A5051000428 @default.
• W2016356630 hasAuthorship W2016356630A5051693361 @default.
• W2016356630 hasAuthorship W2016356630A5052633473 @default.
• W2016356630 hasAuthorship W2016356630A5059371192 @default.
• W2016356630 hasAuthorship W2016356630A5065174129 @default.
• W2016356630 hasAuthorship W2016356630A5077161809 @default.
• W2016356630 hasAuthorship W2016356630A5084303270 @default.
• W2016356630 hasBestOaLocation W20163566301 @default.
• W2016356630 hasConcept C10515644 @default.
• W2016356630 hasConcept C120665830 @default.
• W2016356630 hasConcept C121332964 @default.
• W2016356630 hasConcept C126322002 @default.
• W2016356630 hasConcept C142462285 @default.
• W2016356630 hasConcept C144024400 @default.
• W2016356630 hasConcept C149923435 @default.
• W2016356630 hasConcept C187212893 @default.
• W2016356630 hasConcept C201903717 @default.
• W2016356630 hasConcept C203014093 @default.
• W2016356630 hasConcept C207103383 @default.
• W2016356630 hasConcept C2993143319 @default.

• next